Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1 | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1

Authors:: Doudou Jing; Wei Wu; Xuanzuo Chen; Hongwei Xiao; Zhenhao Zhang; Fengxia Chen; Zhicai Zhang; Jianxiang Liu; Zengwu Shao; Feifei Pu

Reference:: Pharmacological Research; 2022; 182; 106287

DOI:: 10.1016/j.phrs.2022.106287

See Abstract

Key Words:: Quercetin; osteosarcoma; JAK2; JH2 domain; liposome; mice; animal experiments

Back to index